Astellas Pharma Inc. (ALPMF)

Astellas Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	17,070	19,482	25,437	28,985	28,585	28,860
Market Cap Growth	-18.52%	-23.41%	-12.24%	1.40%	-0.95%	0.37%
Enterprise Value	22,226	23,576	22,597	26,106	25,824	26,309
Last Close Price	8.87	10.93	13.98	15.17	15.17	15.59
PE Ratio	-	172.88	34.26	28.37	26.22	15.89
PS Ratio	1.44	1.84	2.23	2.72	2.53	2.39
PB Ratio	1.80	1.85	2.24	2.41	2.28	2.41
P/TBV Ratio	-	-	5.48	6.59	7.02	10.97
P/FCF Ratio	21.04	21.92	11.61	15.53	11.48	17.18
P/OCF Ratio	16.22	17.09	10.32	13.67	10.30	13.99
EV/Sales Ratio	1.70	2.22	1.98	2.45	2.29	2.18
EV/EBITDA Ratio	7.98	12.63	8.90	10.64	8.83	8.48
EV/EBIT Ratio	16.08	28.62	12.97	14.53	11.38	10.58
EV/FCF Ratio	27.39	26.53	10.31	13.98	10.37	15.66
Debt / Equity Ratio	0.61	0.63	0.14	0.15	0.20	0.32
Debt / EBITDA Ratio	2.29	3.57	0.61	0.72	0.86	1.25
Debt / FCF Ratio	7.18	7.50	0.70	0.94	1.01	2.30
Asset Turnover	0.55	0.53	0.63	0.56	0.54	0.62
Inventory Turnover	1.35	1.38	1.76	1.60	1.56	1.83
Quick Ratio	0.73	0.69	1.13	1.05	1.15	0.86
Current Ratio	1.05	0.93	1.45	1.34	1.47	1.09
Return on Equity (ROE)	-3.83%	1.10%	6.65%	8.72%	9.01%	15.34%
Return on Assets (ROA)	3.67%	2.58%	6.05%	5.92%	6.83%	7.93%
Return on Capital (ROIC)	5.24%	3.61%	8.55%	8.17%	9.31%	11.27%
Return on Capital Employed (ROCE)	8.70%	5.50%	13.40%	13.30%	14.90%	17.60%
Earnings Yield	-2.14%	0.58%	2.92%	3.52%	3.81%	6.29%
FCF Yield	4.75%	4.56%	8.62%	6.44%	8.71%	5.82%
Dividend Yield	5.70%	4.23%	3.23%	2.71%	2.50%	2.38%
Payout Ratio	-	684.38%	101.66%	68.69%	63.15%	37.63%
Buyback Yield / Dilution	0.88%	1.39%	1.38%	0.41%	1.03%	2.91%
Total Shareholder Return	6.58%	5.63%	4.61%	3.12%	3.53%	5.29%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.